Decision No 2/2023 of the Joint Committee established by the Agreement on the Withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 3 July 2023 adding two newly adopted Union acts to Annex 2 to the Windsor Framework (2023/1522)
Date: 2023-07-03
Institutions: EU–United Kingdom Joint Committee
Subjects: Northern Ireland, United Kingdom, agreement (EU), application of EU law, pharmaceutical legislation, plant health control, protocol to an agreement, revision of an agreement, surveillance concerning imports, veterinary inspection




L_2023184EN.01010901.xml










21.7.2023   


EN


Official Journal of the European Union


L 184/109








            DECISION No 2/2023 OF THE JOINT COMMITTEE ESTABLISHED BY THE AGREEMENT ON THE WITHDRAWAL OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND FROM THE EUROPEAN UNION AND THE EUROPEAN ATOMIC ENERGY COMMUNITY
         
of 3 July 2023
         
adding two newly adopted Union acts to Annex 2 to the Windsor Framework (2023/1522)


THE JOINT COMMITTEE,

Having regard to the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community (1) (the ‘Withdrawal Agreement’), and in particular Article 13(4) of the Windsor Framework (2),

Whereas:







(1)


Article 13(4) of the Windsor Framework empowers the Joint Committee established under Article 164(1) of the Withdrawal Agreement (the ‘Joint Committee’) to adopt decisions adding newly adopted Union acts falling within the scope of the Windsor Framework to the relevant Annexes to the Windsor Framework. Pursuant to Article 166(2) of the Withdrawal Agreement, the decisions adopted by the Joint Committee are binding on the Union and the United Kingdom. The Union and the United Kingdom are to implement such decisions, which have the same legal effect as the Withdrawal Agreement.












(2)


Two newly adopted Union acts should be added to Annex 2 to the Windsor Framework,





HAS ADOPTED THIS DECISION:



Article 1

1.   Regulation (EU) 2023/1182 of the European Parliament and of the Council of 14 June 2023 on specific rules relating to medicinal products for human use intended to be placed on the market in Northern Ireland and amending Directive 2001/83/EC (3), insofar as it does not amend Directive 2001/83/EC, shall be added to Annex 2 to the Windsor Framework under point 20 ‘Medicinal products’.


2.   Regulation (EU) 2023/1231 of the European Parliament and of the Council of 14 June 2023 on specific rules relating to the entry into Northern Ireland from other parts of the United Kingdom of certain consignments of retail goods, plants for planting, seed potatoes, machinery and certain vehicles operated for agricultural or forestry purposes, as well as non-commercial movements of certain pet animals into Northern Ireland (4) shall be added to Annex 2 to the Windsor Framework under point 44 ‘Sanitary and phytosanitary – Other’.



Article 2
This Decision shall enter into force on the day following that of its adoption.




Done at Brussels, 3 July 2023.


For the Joint Committee


The Co-chairs

Maroš ŠEFČOVIČ
            
James CLEVERLY
            





(1)  
            OJ L 29, 31.1.2020, p. 7.

(2)  Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023 (OJ L 102, 17.4.2023, p. 87).

(3)  
            OJ L 157, 20.6.2023, p. 1.

(4)  
            OJ L 165, 29.6.2023, p. 103.